Adverse effects associated with discontinuation of treatment were hyperglycemia ( 1 subject in the monotherapy trial ) and hypokinesia and tardive dyskinesia ( 1 subject each in adjunctive therapy trial ) .

与治疗中止有关的副作用是高血糖（单一治疗试验中有一例）和运动功能减退及迟发性运动障碍（在联用治疗试验中各一例）。